Nivolumab in MGMT methylated GBM

from Neuro-Oncology: The Podcast · host Dr. Jasmin Jo, Dr. Michael Lim, Dr. Iyad Alnahhas

Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.

Episode metadata supplied by the publisher feed · Published Jan 27, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Nivolumab in MGMT methylated GBM

0:00 20:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 20 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on January 27, 2023.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!